<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>&lt;em&gt;Trypanosoma cruzi&lt;/em&gt; infection prevalence estimates for countries in which vector-borne transmission occurs or has occurred in the past</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center"><em>Trypanosoma cruzi</em> infection prevalence estimates for countries in which vector-borne transmission occurs or has occurred in the past</h1>
<div class="graphic"><div class="figure"><div class="ttl"><em>Trypanosoma cruzi</em> infection prevalence estimates for countries in which vector-borne transmission occurs or has occurred in the past</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Region</td> <td class="subtitle1">Endemic countries</td> <td class="subtitle1">Estimated seroprevalence (%)*</td> <td class="subtitle1">Estimated number of infected individuals*</td> </tr> <tr> <td class="divider_bottom" rowspan="2">North America</td> <td>United States<sup>¶</sup></td> <td>NDA</td> <td>300,000</td> </tr> <tr class="divider_bottom"> <td>Mexico</td> <td>0.78</td> <td>876,000</td> </tr> <tr> <td class="divider_bottom" rowspan="7">Central America</td> <td>Belize<sup>Δ</sup></td> <td>0.33</td> <td>1000</td> </tr> <tr> <td>Costa Rica<sup>Δ</sup></td> <td>0.17</td> <td>8000</td> </tr> <tr> <td>El Salvador<sup>Δ</sup></td> <td>1.30</td> <td>90,000</td> </tr> <tr> <td>Guatemala<sup>Δ</sup></td> <td>1.23</td> <td>167,000</td> </tr> <tr> <td>Honduras<sup>Δ</sup></td> <td>0.92</td> <td>73,000</td> </tr> <tr> <td>Nicaragua<sup>Δ</sup></td> <td>0.52</td> <td>29,000</td> </tr> <tr class="divider_bottom"> <td>Panama<sup>Δ</sup></td> <td>0.52</td> <td>18,000</td> </tr> <tr> <td rowspan="11">South America</td> <td>Argentina<sup>◊</sup></td> <td>3.64</td> <td>1,505,000</td> </tr> <tr> <td>Bolivia<sup>◊</sup><sup>§</sup></td> <td>6.10</td> <td>607,000</td> </tr> <tr> <td>Brazil<sup>◊</sup><sup>§</sup></td> <td>0.61</td> <td>1,157,000</td> </tr> <tr> <td>Chile<sup>◊</sup></td> <td>0.70</td> <td>120,000</td> </tr> <tr> <td>Colombia<sup>§</sup><sup>¥</sup></td> <td>0.96</td> <td>438,000</td> </tr> <tr> <td>Ecuador<sup>§</sup><sup>¥</sup></td> <td>1.38</td> <td>200,000</td> </tr> <tr> <td>French Guiana<sup>§</sup></td> <td>0.84</td> <td>13,000</td> </tr> <tr> <td>Paraguay<sup>◊</sup></td> <td>2.13</td> <td>185,000</td> </tr> <tr> <td>Peru<sup>§</sup><sup>¥</sup></td> <td>0.44</td> <td>128,000</td> </tr> <tr> <td>Uruguay<sup>◊</sup></td> <td>0.24</td> <td>8000</td> </tr> <tr> <td>Venezuela<sup>§</sup><sup>¥</sup></td> <td>0.71</td> <td>193,000</td> </tr> </tbody></table></div><div class="graphic_footnotes">NDA: no data available.<br/>* Disease burden estimates based on references<sup>[1-3]</sup>.<br/>¶ The United States is not generally considered endemic, but established enzootic transmission cycles exist across the southern half of the country. Documented local transmission to humans is rare, but infected vectors and reservoir hosts are fairly frequent. Nevertheless, the vast majority of infected individuals living in the United States are immigrants who were infected in their country of origin.<br/>Δ Member countries of Initiative of the Countries of Central America for Control of Vector-Borne and Transfusional Transmission and Medical Care for Chagas Disease (IPCA).<br/><span class="lozenge">◊</span> Member countries of the Southern Cone Initiative to Control/Eliminate Chagas Disease (INCOSUR).<br/>§ Member countries of Initiative of the Amazon Countries for Surveillance and Control of Chagas Disease (AMCHA).<br/>¥ Member countries of Initiative of the Andean Countries to Control Vectoral and Transfusional Transmission of Chagas Disease (IPA).</div><div class="graphic_reference">References:

<ol>
<li>Chagas disease in Latin America: An epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 2015; 90:33. </li>
<li>Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009; 49:e52. </li>
<li>Manne-Goehler J, Umeh CA, Montgomery SP, Wirtz VJ. Estimating the burden of Chagas disease in the United States. PLoS Negl Trop Dis 2016; 10:e0005033.</li>
</ol></div><div id="graphicVersion">Graphic 58263 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
